Koers OWC Pharmaceutical Research Corp.
Aandelen
OWCP
US67109N1081
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -99,00% |
|
0,00% | 0,00% |
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 15,37 mln. 14,37 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -4 mln. -3,74 mln. | Nettowinst (verlies) 2018 | -10 mln. -9,35 mln. | EV/omzet 2017 | - |
Nettoliquiditeiten 2017 | 971K 907K | Nettoliquiditeiten 2018 | 3,46 mln. 3,24 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 |
-14,5
x | K/w-verhouding 2018 |
-1,21
x | Werknemers | 9 |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
1 dag | -99,00% |
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 16-06-14 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 02-11-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 25-06-20 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 21-06-20 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
14-06-24 | 0,000001 | -99,00% | 87 000 |
13-06-24 | 0,0001 | +9.900,00% | 200 |
uitgestelde koers OTC Markets, 14 juni 2024 om 19:41 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
0,00% | 497 | |
-26,26% | 16,26 mld. | |
-50,54% | 2,44 mld. | |
+25,26% | 1,98 mld. | |
-8,81% | 1,52 mld. | |
+28,12% | 1,3 mld. | |
-18,54% | 937 mln. | |
-32,14% | 775 mln. | |
-1,69% | 760 mln. | |
-26,54% | 615 mln. |